August 5th 2019, 9:19pm
The executive director of the Cancer Policy Institute at the Cancer Support Community offers some candid advice for individuals who may be facing a new cancer diagnosis.
July 29th 2019, 6:05pm
The merging of MyLifeLine.org with Cancer Support Community facilitates more comprehensive social and emotional support for patients and caregivers affected by cancer.
July 24th 2019, 1:00am
Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.
July 23rd 2019, 7:00pm
Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.
July 23rd 2019, 12:00am
Patients with breast cancer can still enroll in a clinical trial that is seeking to find the cause behind cardiac toxicity related to anthracycline-based treatment.
July 19th 2019, 5:00pm
Researchers examined what goes into treatment decision-making for patients with multiple myeloma.
July 17th 2019, 8:32pm
With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.
July 15th 2019, 10:05pm
With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.
July 15th 2019, 6:42pm
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
July 15th 2019, 5:20pm
A breast cancer survivor and hereditary cancer expert discussed how patients can find accurate information about genetic mutations.
Ayvakit Shows Promise for Patients with Gastrointestinal Stomach Tumors With Specific Mutation
Survivorship Champions
FDA Approves Opdivo for the Frontline Treatment of Gastric Cancer
Learning to be a Kinder Person After Cancer
